These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8259163)

  • 41. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 42. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B
    Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract]   [Full Text] [Related]  

  • 43. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Where has WHI led us now?
    Stevenson JC
    Maturitas; 2004 May; 48(1):1-2. PubMed ID: 15223099
    [No Abstract]   [Full Text] [Related]  

  • 46. Indications for hormone therapy: the post-Women's Health Initiative era.
    Reed SD; Newton KM; Lacroix AZ
    Endocrinol Metab Clin North Am; 2004 Dec; 33(4):691-715. PubMed ID: 15501641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One conclusion may hide another.
    CMAJ; 2002 Aug; 167(4):329, 331. PubMed ID: 12197679
    [No Abstract]   [Full Text] [Related]  

  • 53. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 54. [Estrogen and cardiovascular diseases].
    Mikkola T; Tikkanen MJ
    Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract]   [Full Text] [Related]  

  • 55. The Women's Health Initiative: an unforgettable decade.
    Pal L; Manson JE
    Menopause; 2012 Jun; 19(6):597-9. PubMed ID: 22648299
    [No Abstract]   [Full Text] [Related]  

  • 56. Hormone replacement therapy: where do we go now?
    Kaunitz AM
    Breast J; 2002; 8(6):329-31. PubMed ID: 12390354
    [No Abstract]   [Full Text] [Related]  

  • 57. Sex and race/ethnicity reporting in clinical trials: a necessity, not an option.
    Blauwet LA
    J Womens Health (Larchmt); 2011 Mar; 20(3):313-4. PubMed ID: 21351875
    [No Abstract]   [Full Text] [Related]  

  • 58. Is the elevated breast cancer risk observed in the WHI study an artifact?
    Kuhl H
    Climacteric; 2004 Sep; 7(3):319-22. PubMed ID: 15669557
    [No Abstract]   [Full Text] [Related]  

  • 59. Biomarkers and the risk of stroke in the Women's Health Initiative.
    Prentice RL
    Womens Health (Lond); 2011 May; 7(3):269-73. PubMed ID: 21612347
    [No Abstract]   [Full Text] [Related]  

  • 60. The Women's Health Initiative - a decade of progress.
    Fenton A; Panay N
    Climacteric; 2012 Jun; 15(3):205. PubMed ID: 22612604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.